311 related articles for article (PubMed ID: 19381017)
1. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury.
Heymann F; Meyer-Schwesinger C; Hamilton-Williams EE; Hammerich L; Panzer U; Kaden S; Quaggin SE; Floege J; Gröne HJ; Kurts C
J Clin Invest; 2009 May; 119(5):1286-97. PubMed ID: 19381017
[TBL] [Abstract][Full Text] [Related]
2. New roles revealed for T cells and DCs in glomerulonephritis.
Kim AH; Markiewicz MA; Shaw AS
J Clin Invest; 2009 May; 119(5):1074-6. PubMed ID: 19422093
[TBL] [Abstract][Full Text] [Related]
3. Antigen presentation by dendritic cells in renal lymph nodes is linked to systemic and local injury to the kidney.
Dong X; Swaminathan S; Bachman LA; Croatt AJ; Nath KA; Griffin MD
Kidney Int; 2005 Sep; 68(3):1096-108. PubMed ID: 16105040
[TBL] [Abstract][Full Text] [Related]
4. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
5. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression.
McLellan AD; Kapp M; Eggert A; Linden C; Bommhardt U; Bröcker EB; Kämmerer U; Kämpgen E
Blood; 2002 Mar; 99(6):2084-93. PubMed ID: 11877283
[TBL] [Abstract][Full Text] [Related]
6. Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression.
Hochheiser K; Heuser C; Krause TA; Teteris S; Ilias A; Weisheit C; Hoss F; Tittel AP; Knolle PA; Panzer U; Engel DR; Tharaux PL; Kurts C
J Clin Invest; 2013 Oct; 123(10):4242-54. PubMed ID: 23999431
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
Kelleher M; Beverley PC
J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
[TBL] [Abstract][Full Text] [Related]
8. Lymph-borne CD8α+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells.
Cerovic V; Houston SA; Westlund J; Utriainen L; Davison ES; Scott CL; Bain CC; Joeris T; Agace WW; Kroczek RA; Mowat AM; Yrlid U; Milling SW
Mucosal Immunol; 2015 Jan; 8(1):38-48. PubMed ID: 24850430
[TBL] [Abstract][Full Text] [Related]
9. Activated CD4+ T cells target mesangial antigens and initiate glomerulonephritis.
Scindia Y; Nackiewicz D; Dey P; Szymula A; Bajwa A; Rosin DL; Bolton WK; Okusa MD; Deshmukh U; Bagavant H
Nephron Exp Nephrol; 2012; 121(1-2):e1-9. PubMed ID: 23095207
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.
Wang Y; Da'Dara AA; Thomas PG; Harn DA
Immunology; 2010 Mar; 129(3):406-17. PubMed ID: 19922421
[TBL] [Abstract][Full Text] [Related]
11. Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model.
Liao H; Franck E; Fréret M; Adriouch S; Baba-Amer Y; Authier FJ; Boyer O; Gherardi RK
Arthritis Rheum; 2012 Oct; 64(10):3441-51. PubMed ID: 22674045
[TBL] [Abstract][Full Text] [Related]
12. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses.
Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H
J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072
[TBL] [Abstract][Full Text] [Related]
13. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
[TBL] [Abstract][Full Text] [Related]
14. Activated Renal Dendritic Cells Cross Present Intrarenal Antigens After Ischemia-Reperfusion Injury.
Snelgrove SL; Lo C; Hall P; Lo CY; Alikhan MA; Coates PT; Holdsworth SR; Hickey MJ; Kitching AR
Transplantation; 2017 May; 101(5):1013-1024. PubMed ID: 27495751
[TBL] [Abstract][Full Text] [Related]
15. Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL.
Luketic L; Delanghe J; Sobol PT; Yang P; Frotten E; Mossman KL; Gauldie J; Bramson J; Wan Y
J Immunol; 2007 Oct; 179(8):5024-32. PubMed ID: 17911587
[TBL] [Abstract][Full Text] [Related]
16. Active dissemination of cellular antigens by DCs facilitates CD8
Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
[TBL] [Abstract][Full Text] [Related]
17. Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination.
Matsuyoshi H; Senju S; Hirata S; Yoshitake Y; Uemura Y; Nishimura Y
J Immunol; 2004 Jan; 172(2):776-86. PubMed ID: 14707047
[TBL] [Abstract][Full Text] [Related]
18. Naive CD8(+) but not CD4(+) T cells induce maturation of dendritic cells.
Schüler T; Blankenstein T
J Mol Med (Berl); 2002 Aug; 80(8):533-41. PubMed ID: 12185454
[TBL] [Abstract][Full Text] [Related]
19. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs.
Semmling V; Lukacs-Kornek V; Thaiss CA; Quast T; Hochheiser K; Panzer U; Rossjohn J; Perlmutter P; Cao J; Godfrey DI; Savage PB; Knolle PA; Kolanus W; Förster I; Kurts C
Nat Immunol; 2010 Apr; 11(4):313-20. PubMed ID: 20190758
[TBL] [Abstract][Full Text] [Related]
20. A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells.
Xiang J; Huang H; Liu Y
J Immunol; 2005 Jun; 174(12):7497-505. PubMed ID: 15944248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
